abagovomab 20
abciximab 24
abituzumab 21
abrilumab 13
actoxumab 11
adalimumab 15
aducanumab 9
afasevikumab 11
alacizumab_pegol 8
alemtuzumab 21
alirocumab 14
amatuximab 29
andecaliximab 19
anifrolumab 14
anrukinzumab 17
aprutumab 16
aprutumab_ixadotin 16
arcitumomab 16
ascrinvacumab 4
atezolizumab 14
atinumab 14
avelumab 9
basiliximab 21
bavituximab 23
begelomab 19
benralizumab 18
bevacizumab_beta 18
bezlotoxumab 11
bimagrumab 9
bleselumab 9
blinatumomab 22
blosozumab 28
bococizumab 14
brazikumab 14
brentuximab_vedotin 18
briakinumab 16
brodalumab 7
brolucizumab 25
brontictuzumab 18
burosumab 14
cabiralizumab 19
camrelizumab 9
canakinumab 19
cantuzumab_ravtansin 31
carlumab 13
carotuximab 13
cergutuzumab_amunaleukin2 23
cergutuzumab_amunaleukin 23
certolizumab_pegol 24
cetiximab 30
citatuzumab_bogatox 25
cixutumumab 16
clivatuzumab_tetraxetan 14
codrituzumab 21
conatumumab 10
concizumab 18
crenezumab 16
crizanlizumab 21
crotedumab 19
dacetuzumab 21
daclizumab 10
dalotuzumab 26
dapirolizumab_pegol 19
daratumumab 12
dectrekumab 10
demcizumab 20
denosumab 8
depatuxizumab 17
depatuxizumab_mafodotin 17
dezamizumab 11
dinutuximab 29
diridavumab 18
domagrozumab 14
drozitumab 8
duligotuzumab 20
durvalumab 8
dusigitumab 11
efalizumab 32
efungumab 20
eldelumab 12
elezanumab 14
elgemtumab 9
elotuzumab 13
emactuzumab 15
emapalumab 21
emibetuzumab 13
enavatuzumab 23
enfortumab_vedotin 13
enoblituzumab 17
enokizumab 20
enoticumab 15
ensituximab 19
eptinezumab 13
erenumab 16
etaracizumab 14
etrolizumab 22
evinacumab 20
evolocumab 8
farletuzumab 3
fasinumab 16
fezakinumab 14
fibatuzumab 8
ficlatuzumab 18
firivumab 24
flanvotumab 11
fletikumab 14
foralumab 12
foravirumab 14
fremanezumab 28
fresolimumab 16
fulranumab 20
futuximab 18
galcanezumab 11
ganitumab 19
gantenerumab 7
gemetuzumab 20
gemtuzumab2 18
gemtuzumab 16
gevokizumab 21
girentuximab 20
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 19
ibalizumab 21
ibritumomab 13
icrucumab 8
idarucizumab 21
ifabotuzumab 8
imalumab 14
imgatuzumab 14
inclacumab 18
indatuximab_ravtansin 19
indusatumab 10
inebilizumab 19
intetumumab 6
iodine_girentuximab 28
ipilimumab 0
iratumumab 4
isatuximab 21
itolizumab 22
ixekizumab 23
labetuzumab_govitecan 18
lambrolizumab 23
lampalizumab 21
lanadelumab 18
landogrozumab 15
laprituximab 22
lebrikizumab 23
lendalizumab 22
lenzilumab 14
lifastuzumab_vedotin 24
ligelizumab 20
lilotomab 23
lirilumab 19
lodelcizumab 15
lokivetmab 16
lorvotuzumab_mertansin 17
lucatumumab 27
lumretuzumab 15
lupartumab 15
lutikizumab 15
margetuximab 29
milatuzumab 26
mirvetuximab 25
mirvetuximab_soravtansin 25
modotuximab 32
mogamulizumab 22
monalizumab 16
motavizumab 23
moxetumomab_pasudotox 19
namilumab 16
naratuximab 23
naratuximab_emtansin 23
narnatumab 14
navicixizumab2 22
navicixizumab 22
navivumab 26
necitumumab 10
nemolizumab 18
nesvacumab 14
nivolumab 11
obiltoxaximab 18
obinutuzumab 30
ocaratuzumab 18
ofatumumab 13
olaratumab 14
olokizumab 23
omalizumab 17
onartuzumab 20
ontuxizumab 15
opicinumab 13
orticumab 11
otelixizumab 35
oxelumab 9
ozanezumab 21
pamrevlumab 11
panobacumab 18
parsatuzumab 24
pasotuxizumab 17
pateclizumab 12
patritumab 10
pembrolizumab 23
perakizumab 21
pidilizumab 13
pinatuzumab_vedotin 16
plozalizumab 23
pogalizumab 17
polatuzumab_vedotin 20
ponezumab 24
prezalumab 12
pritoxaximab 22
quilizumab 19
racotumomab 22
radretumab 13
ralpancizumab 19
ramucirumab 11
ranevetmab 23
ranibizumab 18
refanezumab 19
remtolumab 16
rilotumumab 13
rinucumab 13
risankizumab 29
rituximab 13
rivabazumab 18
robatumumab 20
roledumab 21
romosozumab 17
rontalizumab 15
rosmantuzumab 20
rozanolixizumab 17
sacituzumab 23
sacituzumab_govitecan 23
samalizumab 17
sapelizumab 21
sarilumab 17
secukinumab 10
seribantumab 15
setoxaximab 29
sifalimumab 6
siltuximab 17
simtuzumab 19
sirukumab 9
solanezumab 26
solitomab 15
stamulumab 15
suptavumab 22
suvizumab 13
tabalumab 10
tadocizumab 10
tamtuvetmab 26
tanezumab 18
tarextumab 8
tavolixizumab 12
telisotuzumab 19
teplizumab 12
tesidolumab 19
tezepelumab 20
tigatuzumab 14
tildrakizumab 15
timolumab 11
tisotumab 9
tosatoxumab 26
tositumomab 13
tralokinumab 21
trastuzumab 23
tregalizumab 21
trevogrumab 11
ublituximab 16
urelumab 14
ustekinumab 25
utomilumab 21
vadastuximab 18
vadastuximab_talirin 18
vandortuzumab_vedotin 14
vantictumab 16
vanucizumab2 18
vanucizumab 23
varlilumab 13
vatelizumab 17
vedolizumab 20
veltuzumab 4
vesencumab 9
vorsetuzumab 19
vorsetuzumab_mafodotin 19
vunakizumab 26
xentuzumab 17
zatuximab 32
